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Primary community-associated methicillin-resistant Staphy-
lococcus aureus (CA-MRSA) endocarditis has rarely been 
reported in healthy individuals without risk factors, such as 
skin and soft tissue infections, and intravenous drug abuse. We 
describe a case of infective endocarditis by CA-MRSA (ST72- 
PVL negative-SCCmec IVA) in previously healthy individuals 
with no underlying medical condition and CA-MRSA coloni-
zation in the family.
Key Words: Endocarditis, colonization in family, community- 
associated methicillin-resistant Staphylococcus aureus
INTRODUCTION
Methicillin-resistant Staphylococcus aureus (MRSA) 
infections have been reported among healthy 
persons who have no prior contact with heal-
thcare system, and these cases have primarily 
been associated with skin and soft-tissue infections 
and severe necrotizing pneumonia, particularly in 
the past decade.
1,2  Although increased incidence 
of community-associated MRSA (CA-MRSA) endo-
carditis has been reported recently, a large pro-
portion of cases had a documented history of skin 
lesion,
3 including furunculosis, cellulitis and/or 
intravenous drug use,
4,5 and CA-MRSA endocarditis 
among individuals with no underlying medical 
condition has rarely been reported. Herein, we 
describe a case of primary infective endocarditis 
caused by CA-MRSA in previously healthy person 
and CA-MRSA colonization in the family.
CASE REPORT
A 39-year-old female was admitted with com-
plaints of intermittent high fever, chill, and 
fatigue of 2 weeks duration. She had no medical 
problems including intravenous drug abuse, un-
derlying heart disease, dental problem, or pre-
vious exposure to healthcare personnel or a hospi-
tal environment. She was living with her parents, 
and her nutritional status was good. On admis-
sion, she appeared acutely ill. Her body tempera-
ture was 39.2°C, her blood pressure was 100/70 
mmHg, her pulse rate was 96/min, and her 
respiratory rate was 24/min. Physical examination 
was negative for the following: conjunctival hemor-
rhage, petechiae, tender nodule, and Janeway 
lesion on the hands. A grade II/VI systolic murmur 
was detected over the cardiac apex. There was 
neither evidence of skin infection nor pneumonia. 
Her initial WBC count was 19,460/mm
3 with 
neutrophilia (90.8%). Urinalysis showed neither 
proteinuria nor hematuria. We conducted a trans-
thoracic echocardiography (TTE) on hospital day 2. 
The TTE showed multiple irregular-shaped mobile 
oscillating echogenic masses on the tips of both 
anterior and posterior mitral leaflets (1.63 cm and 
0.7 cm, respectively), with trivial mitral regurgi-
tation and normal LV function (Ejection Fraction= 
64%, Fig. 1). Empirical antibiotic treatment with Primary Infective Endocarditis by CA-MRSA 153
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Fig. 1. Transthoracic echocardiography shows vegetations (arrows) on both mitral leaflets; (A) Diastole. (B) Systole. LA, left
atrium; LV, left ventricle; Ao, aorta. 
Fig. 2. Molecular profiling (A) Pulsed-field gel electrophoresis analysis shows clonal relationship between 4 community-
associated methicillin-resistant Staphylococcus aureus isolates. M, Marker; B1, Blood isolate of the patient; N1, Nasal isolate
of the patient; N2, Nasal isolate of the patient’s father; N3, Nasal isolate of the patient’s brother-in-law; C, Control. (B)
All 4 community-associated methicillin-resistant Staphylococcus aureus isolates were Panton-Valentine leukocidin (PVL)- 
negative SCCmec IVA clone. M, Marker; B1, Blood isolate of the patient; N1, Nasal isolate of the patient; N2, Nasal isolate
of the patient’s father; N3, Nasal isolate of the patient’s brother-in-law; PII, SCCmec II positive sample; PIII, SCCmec III
positive sample; PIV, SCCmec IV positive sample.
intravenous penicillin-G and gentamicin were 
initially given. On hospital day 4, she complained 
of right arm motor weakness (GII/V), aphasia, and 
altered mental status. Brain MRI revealed multi-
focal acute infarctions in both frontoparietal lobes. 
Two separate blood cultures taken at admission 
were positive for MRSA. The isolate was found to 
be susceptible to ciprofloxacin, clindamycin, 
erythromycin, gentamicin, rifampin, tetracycline, 
and trimethoprim-sulfamethoxazole, but resistant 
to oxacillin and penicillin. Penicillin-G was, there-
fore, replaced with vancomycin. On hospital day 
8, surgical intervention was performed because of 
poor response to medical therapy and large hyper-
mobile vegetations. The extirpated vegetation 
tissues cultured during surgery were positive for 
MRSA with the antimicrobial susceptibility similar 
to that of blood isolate. She received 6 weeks of 
intravenous vancomycin and 2 weeks of intraven-
ous gentamicin post-operatively. Six weeks after 
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surgery, a follow-up TTE was negative for vegeta-
tion, and she was transferred to the Department 
of Rehabilitation. She was discharged on hospital 
day 121, and she had no disease recurrence at 1 
year follow up.
MRSA surveillance cultures were obtained from 
nasal swab of the patient and her family (parents, 
3 sisters, a brother-in-law, and a brother; all had 
no previous medical history in the last several 
years). Among the 6 family members investigated, 
2 (the father and the brother-in-law) were positive 
for MRSA surveillance cultures with the anti-
microbial susceptibility similar to that of the 
patient. We performed multiplex PCR for the 
detection of the Panton-Valentine leukocidin (PVL) 
gene and SCCmec typing,
6 multilocus sequence 
typing (MLST), and pulsed-field gel electropho-
resis (PFGE). MRSA isolates from 2 family members 
showed a PFGE pattern similar to that of the 
patient. All MRSA isolates from the patient (blood 
and nasal surveillance) and 2 family members 
were PVL-negative SCCmec IVA type; the MLST 
allelic profile revealed ST72; 1-4-1-8-4-4-3 (Fig. 2).
DISCUSSION 
Emergence of MRSA as a cause of infection in 
the community is a significant concern.
1,2  More 
recently, infective endocarditis (IE) due to the 
involvement of CA-MRSA has been described.
5,7 
In these studies, most of the patients did not have 
traditional risk factors for the acquisition of IE, 
e.g., structural heart disease or prior rheumatic 
fever.
7 In the majority of cases reported, CA-MRSA 
endocardial infection developed in intravenous 
drug users and after development of furunculosis 
and abscesses, osteomyelitis, or pneumonia.
3-5,7 
Although CA-MRSA IE has increased dramatically 
in the USA, especially associated with injection 
drug use,
5,8 CA-MRSA endocarditis among indivi-
duals with no underlying medical condition has 
rarely been reported. To the best of our know-
ledge, only a single case of CA-MRSA native valve 
endocarditis among non-intravenous drug users 
with no preceding infections has so far been 
reported.
9
In Korea, MRSA accounts for more than 60% of 
S. aureus in hospital settings, however, CA-MRSA 
infections are not common and have rarely been 
reported.
10 A survey of CA-MRSA in Korea re-
vealed that skin and soft tissue infections or ear 
infections were common, and that a new clone of 
CA-MRSA (ST72-SCCmec IVA) without the PVL 
gene was the most common form among pathogens 
and colonizers, differing in several characteristics 
from those of other countries.
11,12 In the present 
case, the causative CA-MRSA was a PVL-negative 
ST72-MRSA-IVA clone, the most common form in 
Korea.
CA-MRSA tends to be more susceptible to non- 
beta-lactam antibiotics than hospital-acquired 
MRSA, nevertheless, the antibiotic management of 
CA-MRSA IE should follow current international 
guidelines for infective endocarditis.
7 We treated 
the patient with vancomycin for 6 weeks according 
to the guidelines.
Colonization is a strong risk factor for sub-
sequent infection, although most persons colo-
nized with the organism do not develop clinical 
disease,
13 and infections caused by S. aureus are 
generally believed to follow colonization of the 
skin or nares of the host.
2,13,14 PFGE revealed that 
the present case of MRSA endocarditis was of 
endogenous origin, since it originated from 
colonies in the nasal mucosa and we were able to 
document clonal CA-MRSA colonization in the 
family. For infection control measures and em-
pirical antibiotic treatment, prevalence and risk 
factor for CA-MRSA colonization and infection 
should be investigated in Korea.
We suggest that CA-MRSA should be con-
sidered a possible etiologic agent of infective 
endocarditis in a healthy individual with no clas-
sical risk factors for the acquisition of MRSA, no 
past history of skin and soft tissue infections, or 
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